Template:Main Page News: Difference between revisions

From Embryology
mNo edit summary
mNo edit summary
Line 1: Line 1:
{| width=700px|
{| width=700px|
|-bgcolor="CEDFF2"  
|-bgcolor="CEDFF2"  
| <span style="font-size:150%">'''News - Australia Gestational Diabetes (2015)'''</span>
| <span style="font-size:150%">'''News - CRISPR Gene Editing'''</span>
|-bgcolor="F5FAFF"  
|-bgcolor="F5FAFF"  
| valign=top| [[File:Australia - insulin-treated diabetes by type 2015.jpg|250px|right|alt=Australia - insulin-treated diabetes by type 2015|link=Australian_Statistics#Incidence_of_insulin-treated_diabetes_in_Australia_2015]]
| valign=top| [[File:CRISPR Cas9 interaction with target DNA.jpg|250px|right|alt=CRISPR Cas9 interaction with target DNA|link=]]
'''Proportion of insulin-treated diabetes by type (2015)''' 20 Feb 2017 AIHW fact sheet provides the latest available national data on new cases of insulin-treated diabetes in Australia. It shows that in 2015 there were 28,775 people who began using insulin to treat their diabetes in Australia and '''26%''' (18,142) had [[Abnormal Development - Maternal Diabetes|gestational diabetes]]. The highest rates of insulin-treated gestational diabetes among women of reproductive age were in women aged 30–34 (307 per 100,000 women of reproductive age). The proportion of women diagnosed with gestational diabetes who required insulin treatment increased with age, peaking among those aged 40–44, with almost 1 in 3 women requiring insulin (30%). Gestational diabetes occurs when higher than normal blood glucose is diagnosed for the first time during pregnancy. It generally occurs in the second or third trimester, among women who have not previously been diagnosed with other forms of diabetes.


Reference: AIHW 2017. Incidence of insulin-treated diabetes in Australia, 2015. Diabetes series no. 27. Cat. no. CVD 78. Canberra: AIHW. Viewed 20 February 2017 http://www.aihw.gov.au/publication-detail/?id=60129558632.
It has been reported (but not confirmed by publication) that USA scientists have [https://www.technologyreview.com/s/608350/first-human-embryos-edited-in-us/amp/ gene-edited embryos using CRISPR]


:'''Links:''' [[Abnormal Development - Maternal Diabetes|Maternal Diabetes]] | [http://www.aihw.gov.au/publication-detail/?id=60129558632 AIWH Factsheet]
This follows on from an earlier 2015 published work ([https://www.ncbi.nlm.nih.gov/pubmed/25894090 PMID 25894090]) from China using the same technique [http://www.nature.com/news/chinese-scientists-genetically-modify-human-embryos-1.17378 see Nature 22 April 2015] and a more recent 2017 paper ([https://www.ncbi.nlm.nih.gov/pubmed/?term=28251317 PMID 28251317]).
 
 
'''About CRISPR'''
 
The CRISPR/Cas9-mediated gene editing system was derived from the adaptive immune system evolved in bacteria to defend against invading plasmids and viruses.
 
:'''Links:''' [[Molecular_Development_-_Genetics#CRISPR|CRISPR]] | [[Molecular_Development_-_Genetics|Genetics]]
|-
|-
|  
|  
:[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]]  | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]]
:[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#February Gestational Diabetes]] | [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]]  | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]]
|}
|}

Revision as of 11:35, 28 July 2017

News - CRISPR Gene Editing
CRISPR Cas9 interaction with target DNA

It has been reported (but not confirmed by publication) that USA scientists have gene-edited embryos using CRISPR

This follows on from an earlier 2015 published work (PMID 25894090) from China using the same technique see Nature 22 April 2015 and a more recent 2017 paper (PMID 28251317).


About CRISPR

The CRISPR/Cas9-mediated gene editing system was derived from the adaptive immune system evolved in bacteria to defend against invading plasmids and viruses.

Links: CRISPR | Genetics
Older News Articles - Template_talk:Main_Page_News#February Gestational Diabetes | Kyoto eBook | Dolly's sisters live on! | Thalidomide in Zebrafish | Human pancreas stem cells | Oral contraceptive no risk of major birth defects | Maternal Malaria Neurovascular Development Effects | Oocyte/Spermatozoa fate decision Rubella eliminated in the Americas | Three-person embryos